CLINICAL EVALUATION OF A NEW ANTHELMINTICTHIABENDAZOLE (2-(4'-THIAZOLYL)-BENZIMIDAZOLE).
D000724:Ancylostomiasis; D000871:Anthelmintics; D001196:Ascariasis; D001562:Benzimidazoles; D001598:Bephenium Compounds; D035843:Biomedical Research; D006725:Hookworm Infections; D006801:Humans; D012500:Santonin; D013750:Tetrachloroethylene; D013827:Thiabendazole; D014116:Toxicology; D014257:Trichuriasis; D014839:Vomiting
D000871:Anthelmintics; D001562:Benzimidazoles; D001598:Bephenium Compounds; D012500:Santonin; C031000:benzimidazole; D013827:Thiabendazole; D013750:Tetrachloroethylene
ANTHELMINTICS; ASCARIASIS; BENZIMIDAZOLES; BEPHENIUM COMPOUNDS; CLINICAL RESEARCH; HOOKWORM INFECTION; SANTONIN; TETRACHLOROETHYLENE; THIABENDAZOLE; TOXICOLOGIC REPORT; TRICHURIASIS; VOMITING